While the inhibition of MMP-2 had beneficial effects in reducing tumor burden and protecting against myeloma induced bone disease, targeting other individual MMPs known to play a role in multiple myeloma progression may be of benefit. This evidence concerns the gene MMP2 and neoplasm.